ES2038623T3 - Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada. - Google Patents

Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada.

Info

Publication number
ES2038623T3
ES2038623T3 ES198787109559T ES87109559T ES2038623T3 ES 2038623 T3 ES2038623 T3 ES 2038623T3 ES 198787109559 T ES198787109559 T ES 198787109559T ES 87109559 T ES87109559 T ES 87109559T ES 2038623 T3 ES2038623 T3 ES 2038623T3
Authority
ES
Spain
Prior art keywords
procedure
oxazaphosphorin
prepare
solutions
improved stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787109559T
Other languages
English (en)
Spanish (es)
Inventor
Dieter Sauerbier
Klaus Dr. Molge
Werner Dr. Weigert
Otto Dr. Isaac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2038623T3 publication Critical patent/ES2038623T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Paper (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
ES198787109559T 1986-07-11 1987-07-03 Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada. Expired - Lifetime ES2038623T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3623369 1986-07-11

Publications (1)

Publication Number Publication Date
ES2038623T3 true ES2038623T3 (es) 1993-08-01

Family

ID=6304930

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787109559T Expired - Lifetime ES2038623T3 (es) 1986-07-11 1987-07-03 Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada.

Country Status (16)

Country Link
US (1) US4952575A (enExample)
EP (1) EP0254902B1 (enExample)
JP (1) JPS6323888A (enExample)
KR (1) KR880001282A (enExample)
AT (1) ATE66609T1 (enExample)
AU (1) AU598282B2 (enExample)
CA (1) CA1289886C (enExample)
DE (2) DE3722043A1 (enExample)
DK (1) DK168322B1 (enExample)
ES (1) ES2038623T3 (enExample)
FI (1) FI86690C (enExample)
GR (1) GR3002618T3 (enExample)
IE (1) IE59897B1 (enExample)
IL (1) IL83141A (enExample)
PT (1) PT85293B (enExample)
ZA (1) ZA875059B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1999018973A2 (de) * 1997-10-13 1999-04-22 Stada Arzneimittel Ag Flüssige darreichungsformen oxazaphosphorinhaltiger pharmazeutischer produkte
US7205404B1 (en) * 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
AUPQ849900A0 (en) * 2000-06-30 2000-07-27 Dbl Australia Pty Ltd. Injectable composition
US6613927B1 (en) 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
EA008776B1 (ru) * 2002-09-05 2007-08-31 Бхарат Сирумс Энд Вэксинс Лтд. Жидкая стабильная композиция оксазафосфорина с месной
US7199111B2 (en) * 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations
CA2580202A1 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
EP3623364A1 (en) 2014-02-13 2020-03-18 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
US20150320774A1 (en) * 2014-05-09 2015-11-12 AuroMedics Pharma LLC Formulations of cyclophosphamide liquid concentrate
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
WO2016005962A2 (en) 2014-07-11 2016-01-14 Dr. Reddy’S Laboratories Limited Stable liquid formulations of cyclophosphamide and processes
US10849916B2 (en) 2014-07-11 2020-12-01 Dr. Reddys Laboratories Limited Stable liquid formulations of cyclophosphamide and its impurities
US10993952B2 (en) 2015-02-16 2021-05-04 Leiutis Pharmaceuticals Pvt. Ltd. Stable ready to use cyclophosphamide liquid formulations
WO2019139919A1 (en) 2018-01-09 2019-07-18 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
US20230310468A1 (en) * 2020-08-17 2023-10-05 Sandoz Ag Parenteral pharmaceutical composition comprising cyclophosphamide and a mixture of liquids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3530147A1 (de) * 1985-08-23 1987-02-26 Bayer Ag Verwendung von diazaphosphorinen zur bekaempfung von endoparasiten

Also Published As

Publication number Publication date
DK168322B1 (da) 1994-03-14
GR3002618T3 (en) 1993-01-25
DK359387A (da) 1988-01-12
EP0254902A2 (de) 1988-02-03
DK359387D0 (da) 1987-07-10
KR880001282A (ko) 1988-04-22
FI86690B (fi) 1992-06-30
FI86690C (fi) 1992-10-12
PT85293B (pt) 1990-03-30
IL83141A (en) 1992-11-15
AU598282B2 (en) 1990-06-21
ATE66609T1 (de) 1991-09-15
IL83141A0 (en) 1987-12-31
DE3772482D1 (de) 1991-10-02
FI873064A0 (fi) 1987-07-10
FI873064L (fi) 1988-01-12
EP0254902A3 (en) 1988-08-03
US4952575A (en) 1990-08-28
AU7554987A (en) 1988-01-14
IE59897B1 (en) 1994-04-20
ZA875059B (en) 1988-02-24
JPH0543711B2 (enExample) 1993-07-02
IE871867L (en) 1988-01-11
JPS6323888A (ja) 1988-02-01
DE3722043A1 (de) 1988-01-14
CA1289886C (en) 1991-10-01
PT85293A (de) 1987-08-01
EP0254902B1 (de) 1991-08-28

Similar Documents

Publication Publication Date Title
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
ES2135058T3 (es) Fosfito monodentado y composicion de catalizador a base de niquel para la hidrocianacion de monoolefinas.
MX171822B (es) Proceso quimico
ES2057754T3 (es) Un derivado de 1-piridilimidazol asi como su produccion y su uso.
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
ES2036551T3 (es) Compuestos heterociclicos.
ES2196305T3 (es) Composiciones que contienen moleculas inmunogenas y factor de estimulacion de colonias de granulocitos magrofagos como adyuvante.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
ES8701733A1 (es) Procedimiento para detectar peroxido de hidrogeno o sustancias formadoras de peroxido de hidrogeno
NO862170L (no) Fremstilling av quinazolinderivater.
ES2028857T3 (es) Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol.
ES552796A0 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
AR246509A1 (es) Una cetimina, su preparacion y un agente de entrecruzamiento que la contiene.
ES2033296T3 (es) Nuevas composiciones cataliticas y procedimiento para la copolimerizacion de olefinas/co
SE8703169L (sv) 1-(4-aminofenyl)-4-metyl-7,8-metylendioxi-3,4-dihydro-5h-2,3-bensodiazepin, syraadditionssalter derav samt forfarande for framstellning av densamma
KR860004049A (ko) 퀴놀론카복실산 유도체의 제조방법
DE3772482D1 (de) Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
ES2070238T3 (es) Emulsion de lipidos que contiene un analogo de prostaglandina.
ES2062649T3 (es) Pigmentos de vanadato de bismuto, procedimientos para su fabricacion asi como su uso.
ES2057322T3 (es) Derivados de amida de aminoacido substituidos, su fabricacion y uso.
KR840006206A (ko) 이소퀴놀린 유도체의 제조방법
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
UA19151A (uk) Спосіб одержаhhя оптичhо активhого (+)-4-деметоксидауhоміциhоhу
ES2038684T3 (es) Procedimiento de preparacion de derivados de octahidroindol y de compuestos intermedios de su preparacion.
KR830004320A (ko) 퀴나졸린 유도체의 제조방법